A 40-year-old woman with T2D and CKD G3bA3 on triple therapy achieves uACR reduction from 120 to 15 mg/mmol over 12 months. Should she stop

Question

A 40-year-old woman with T2D and CKD G3bA3 on triple therapy achieves uACR reduction from 120 to 15 mg/mmol over 12 months. Should she stop renoprotective agents now albuminuria has improved?

Accepted Answer

No – all agents should continue

Answer

Stop SGLT2i as the next step

Answer

Only continue Ramipril as the next step

Answer

Stop Finerenone as the next step

Answer

Stop all three as the next step

Continue Agents After Improvement — ESENeph MCQ

A 40-year-old woman with T2D and CKD G3bA3 on triple therapy achieves uACR reduction from 120 to 15 mg/mmol over 12 months. Should she stop renoprotective agents now albuminuria has improved?